National Center for Injury Prevention and Control (NCIPC), Board of Scientific Counselors, National Center for Injury Prevention and Control, (BSC, NCIPC), 49657-49658 [2016-17797]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 145 / Thursday, July 28, 2016 / Notices
Lhorne on DSK30JT082PROD with NOTICES
guidance and expectations contained in
recent supervisory letters, notably SR
Letter 15–18. SR Letter 15–18 outlines
expectations regarding a firm’s risk
management infrastructure and strength
of associated processes.
In order to capture the information
surrounding the risk management
infrastructure and processes as outlined
in SR Letter 15–18, the Board proposes
adding two sub-schedules to the FR Y–
14A Schedule E (Operational Risk) and
modifying the supporting
documentation requirements for this
schedule effective with the reports as-of
December 31, 2016. First, new subschedule E.2, Material Risk
Identification, would collect
information on a firm’s material
operational risks included in loss
projections based on their risk
management framework, a component
of risk management emphasized in SR
Letter 15–18. Second, new sub-schedule
E.3, Operational Risk Scenarios, would
collect a firm’s operational risk
scenarios included in the BHC Baseline
and BHC Stress projections, a
fundamental element of the framework.
Finally, the Board recommends
updating the requirements for
supporting documentation and
modifying certain terminology,
definitions, and references to align with
SR Letter 15–18.
Certain information related to the
previous methodology are no longer
necessary to collect given the
aforementioned change in guidance,
resulting in the proposed removal of
these items and updating of associated
terminology. Sub-schedule E.1 (BHC
Operational Risk Historical Capital)
would be removed as this schedule
pertains to Advanced Measurement
Approaches (AMA) methodology and
these data are no longer necessary. This
change in methodology also results in
the removal of two associated columns
on the FR Y–14A Schedule A.6
(Operational Risk Scenario Inputs and
Projections): Type of Data and Brief
Description. References to previous
methodology would be updated,
including changing the name of a
column on the FR Y–14A Schedule A.6
(Operational Risk Scenario Inputs and
Projections) from Units of Measure to
Risk Segment. These changes would
also be effective with the report as-of
December 31, 2016.
Proposed Revisions to the FR Y–14Q
The proposed revision to the FR Y–
14Q consists of adding an item to more
accurately collect information that is
currently derived. This proposed change
would allow for more accurate and
consistent reporting of information with
VerDate Sep<11>2014
14:44 Jul 27, 2016
Jkt 238001
minimal anticipated burden on
respondents.
Schedule B (Securities)
For reports as-of December 31, 2016,
the Board proposes adding a new
column to the FR Y–14Q Schedule B.1
(Securities 1—Main Schedule) to collect
the price of the security to more
accurately collect price information and
thereby enhance supervisory modeling.
Because this information is believed to
be readily available, the Board estimates
this revision would impose minimal
additional burden while improving the
ability to use these data.
Proposed Revisions to the FR Y–14M
Schedule D (Credit Card)
For reports as-of December 31, 2016,
the Board proposes modifying the
definition of Item 62, Gross Charge-off
Amount—Current month to reflect the
intended method of reporting the item
and in response to industry comments.
The definition would be modified to
indicate that all gross charge-offs must
be reported regardless of whether they
are from purchased or impaired loans by
eliminating the reference to allowance
for loan and lease losses (ALLL).
Board of Governors of the Federal Reserve
System, July 25, 2016.
Robert deV. Frierson,
Secretary of the Board.
[FR Doc. 2016–17876 Filed 7–27–16; 8:45 am]
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
49657
for Health (ASH), the Director, CDC, and
the Director, Office of Public Health
Preparedness and Response (OPHPR),
concerning strategies and goals for the
programs and research within OPHPR,
monitoring the overall strategic
direction and focus of the OPHPR
Divisions and Offices, and
administration and oversight of peer
review of OPHPR scientific programs.
For additional information about the
Board, please visit: https://www.cdc.gov/
phpr/science/counselors.htm.
Matters for Discussion: The meeting
will cover administrative updates;
updates from the Director, OPHPR;
status updates on BSC
recommendations from the April 11–12,
2016 BSC Meeting; and deliberation on
potential topics for the October 25–26,
2016 BSC Meeting. Agenda items are
subject to change as priorities dictate.
Contact Person for More Information:
Dometa Ouisley, Office of Science and
Public Health Practice, Centers for
Disease Control and Prevention, 1600
Clifton Road NE., Mailstop D–44,
Atlanta, Georgia 30333, Telephone:
(404) 639–7450; Facsimile: (404)639–
7977; Email: OPHPR.BSC.Questions@
cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
Prevention, and Agency for Toxic
Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and
Service Office, Centers for Disease Control
and Prevention.
Board of Scientific Counselors, Office
of Public Health Preparedness and
Response; Meetings
[FR Doc. 2016–17826 Filed 7–27–16; 8:45 am]
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Time and Date: 3 p.m.–5 p.m., EDT,
August 19, 2016.
Place: Web conference via Adobe
Connect.
Link: https://ophprbsc.adobeconnect.com/august2016/.
Dial-In Number: (877)327–8109.
Participant Code: 2108386.
Status: This meeting is open to the
public.
Purpose: This Board is charged with
providing advice and guidance to the
Secretary, HHS, the Assistant Secretary
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
National Center for Injury Prevention
and Control (NCIPC), Board of
Scientific Counselors, National Center
for Injury Prevention and Control,
(BSC, NCIPC)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) announce
the following meeting of the
aforementioned committee.
Times and Dates: 1:00 p.m.–4:45 p.m.
EDT, September 7, 2016 (OPEN); 8:30
E:\FR\FM\28JYN1.SGM
28JYN1
Lhorne on DSK30JT082PROD with NOTICES
49658
Federal Register / Vol. 81, No. 145 / Thursday, July 28, 2016 / Notices
a.m.–3:30 p.m. EDT, September 8, 2016
(OPEN).
Place: Centers for Disease Control and
Prevention, Thomas R. Harkins Global
Communication Center, Building 19,
Auditorium B–3, 1600 Clifton Road NE.,
Atlanta, Georgia 30333. This meeting is
also accessible by teleconference.
Dial-In Number: 1–877–937–9818,
Participant Code: 7551384 Link to
Adobe Connect: https://
violenceprevention.adobeconnect.com/
bcs2/.
Status: This meeting is open to the
public limited only by the space and
ports available. The meeting room
accommodates 200 participants and
there will be 100 ports available. There
will be public comment periods at the
end of each meeting day; September 7,
2016 from 4:05 p.m.–4:35 p.m. and
September 8, 2016 from 1:45 p.m.–2:00
p.m.
Purpose: The Board will: (1) Conduct,
encourage, cooperate with, and assist
other appropriate public health
authorities, scientific institutions, and
scientists in the conduct of research,
investigations, experiments,
demonstrations, and studies relating to
the causes, diagnosis, treatment, control,
and prevention of physical and mental
diseases, and other impairments; (2)
assist States and their political
subdivisions in preventing and
suppressing communicable and noncommunicable diseases and other
preventable conditions and in
promoting health and well-being; and
(3) conduct and assist in research and
control activities related to injury.
The Board of Scientific Counselors
makes recommendations regarding
policies, strategies, objectives, and
priorities; and reviews progress toward
injury prevention goals and provides
evidence in injury prevention-related
research and programs. The Board also
provides advice on the appropriate
balance of intramural and extramural
research, the structure, progress and
performance of intramural programs.
The Board is designed to provide
guidance on extramural scientific
program matters, including the: (1)
Review of extramural research concepts
for funding opportunity
announcements; (2) conduct of
Secondary Peer Review of extramural
research grants, cooperative agreements,
and contracts applications received in
response to the funding opportunity
announcements as it relates to the
Center’s programmatic balance and
mission; (3) submission of secondary
review recommendations to the Center
Director of applications to be considered
for funding support; (4) review of
VerDate Sep<11>2014
14:44 Jul 27, 2016
Jkt 238001
research portfolios, and (5) review of
program proposals.
Matters for Discussion: The Board of
Scientific Counselors will discuss
science matters to include research
strategies needed to guide the Center’s
focus, as well as an update from the
BSC, Pediatric Mild Traumatic Brain
Injury (TBI) Work Group on its
considerations for the Pediatric TBI
Guideline project. The workgroup report
on the protocol and systematic review of
the acute identification, diagnosis, and
management of children with mild
Traumatic Brain Injury guideline will be
posted to the BSC Web site prior to the
meeting; https://www.cdc.gov/injury/bsc/
index.html.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Gwendolyn H. Cattledge, Ph.D.,
M.S.E.H., Deputy Associate Director for
Science, NCIPC, CDC, 4770 Buford
Highway, NE., Mailstop F–63, Atlanta,
GA 30341, Telephone (770) 488–1430;
Email: ncipcbsc@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2016–17797 Filed 7–27–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Request for Nominations of
Candidates To Serve on the Advisory
Committee to the Director, Centers for
Disease Control and Prevention (ACD,
CDC)
The Centers for Disease Control and
Prevention (CDC) is soliciting
nominations for possible membership
on the ACD, CDC. ACD, CDC consists of
15 experts in fields related to health
policy, public health, global health,
preparedness, preventive medicine, the
faith-based and community-based
sector, and allied fields, who are
selected by the Secretary of the U.S.
Department of Health and Human
Services (HHS). The committee advises
the HHS Secretary and the CDC Director
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
concerning policy and broad strategies
that will enable CDC to fulfill its
mission of protecting health through
health promotion, prevention, and
preparedness. The committee
recommends ways to prioritize CDC’s
activities, improve results, and address
health disparities. It also provides
guidance to help CDC work more
effectively with its various private and
public sector constituents to make
health protection a practical reality.
Nominations are being sought for
individuals who have the expertise and
qualifications necessary to contribute to
accomplishment of the committee’s
objectives. Nominees will be selected by
the HHS Secretary or designee from
authorities knowledgeable in the fields
of public health as well as from the
general public. Federal employees will
not be considered for membership.
Members may be invited to serve for
terms of up to four years.
The U.S. Department of Health and
Human Services policy stipulates that
committee membership be balanced in
terms of points of view represented and
the committee’s function. Consideration
will be given to a broad representation
of geographic areas. Appointments shall
be made without discrimination on the
basis of age, race, ethnicity, gender,
sexual orientation, gender identity, HIV
status, disability, and cultural, religious,
or socioeconomic status. Nominees
must be U.S. citizens and cannot be fulltime employees of the U.S. Government.
Current participation on federal
workgroups or prior experience serving
on a federal advisory committee does
not disqualify a candidate; however,
HHS policy is to avoid excessive
individual service on advisory
committees and multiple committee
memberships. Committee members are
Special Government Employees,
requiring the filing of financial
disclosure reports at the beginning and
annually during their terms. CDC
reviews potential candidates for ACD,
CDC membership each year and
provides a slate of nominees for
consideration to the Secretary of HHS
for final selection. HHS notifies selected
candidates of their appointment near
the start of the term in July 2017 or as
soon as the HHS selection process is
completed. Note that the need for
different expertise varies from year to
year and a candidate who is not selected
in one year may be reconsidered in a
subsequent year.
Nominees must be U.S. citizens and
cannot be full-time employees of the
U.S. Government. Candidates should
submit the following items:
• Current curriculum vitae, including
complete contact information (name,
E:\FR\FM\28JYN1.SGM
28JYN1
]]>Agencies
[Federal Register Volume 81, Number 145 (Thursday, July 28, 2016)]
[Notices]
[Pages 49657-49658]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-17797]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
National Center for Injury Prevention and Control (NCIPC), Board
of Scientific Counselors, National Center for Injury Prevention and
Control, (BSC, NCIPC)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announce the following meeting of the aforementioned
committee.
Times and Dates: 1:00 p.m.-4:45 p.m. EDT, September 7, 2016 (OPEN);
8:30
[[Page 49658]]
a.m.-3:30 p.m. EDT, September 8, 2016 (OPEN).
Place: Centers for Disease Control and Prevention, Thomas R.
Harkins Global Communication Center, Building 19, Auditorium B-3, 1600
Clifton Road NE., Atlanta, Georgia 30333. This meeting is also
accessible by teleconference.
Dial-In Number: 1-877-937-9818, Participant Code: 7551384 Link to
Adobe Connect: https://violenceprevention.adobeconnect.com/bcs2/.
Status: This meeting is open to the public limited only by the
space and ports available. The meeting room accommodates 200
participants and there will be 100 ports available. There will be
public comment periods at the end of each meeting day; September 7,
2016 from 4:05 p.m.-4:35 p.m. and September 8, 2016 from 1:45 p.m.-2:00
p.m.
Purpose: The Board will: (1) Conduct, encourage, cooperate with,
and assist other appropriate public health authorities, scientific
institutions, and scientists in the conduct of research,
investigations, experiments, demonstrations, and studies relating to
the causes, diagnosis, treatment, control, and prevention of physical
and mental diseases, and other impairments; (2) assist States and their
political subdivisions in preventing and suppressing communicable and
non-communicable diseases and other preventable conditions and in
promoting health and well-being; and (3) conduct and assist in research
and control activities related to injury.
The Board of Scientific Counselors makes recommendations regarding
policies, strategies, objectives, and priorities; and reviews progress
toward injury prevention goals and provides evidence in injury
prevention-related research and programs. The Board also provides
advice on the appropriate balance of intramural and extramural
research, the structure, progress and performance of intramural
programs. The Board is designed to provide guidance on extramural
scientific program matters, including the: (1) Review of extramural
research concepts for funding opportunity announcements; (2) conduct of
Secondary Peer Review of extramural research grants, cooperative
agreements, and contracts applications received in response to the
funding opportunity announcements as it relates to the Center's
programmatic balance and mission; (3) submission of secondary review
recommendations to the Center Director of applications to be considered
for funding support; (4) review of research portfolios, and (5) review
of program proposals.
Matters for Discussion: The Board of Scientific Counselors will
discuss science matters to include research strategies needed to guide
the Center's focus, as well as an update from the BSC, Pediatric Mild
Traumatic Brain Injury (TBI) Work Group on its considerations for the
Pediatric TBI Guideline project. The workgroup report on the protocol
and systematic review of the acute identification, diagnosis, and
management of children with mild Traumatic Brain Injury guideline will
be posted to the BSC Web site prior to the meeting; https://www.cdc.gov/injury/bsc/.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Gwendolyn H. Cattledge, Ph.D.,
M.S.E.H., Deputy Associate Director for Science, NCIPC, CDC, 4770
Buford Highway, NE., Mailstop F-63, Atlanta, GA 30341, Telephone (770)
488-1430; Email: ncipcbsc@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2016-17797 Filed 7-27-16; 8:45 am]
BILLING CODE 4163-18-P
